Foot orthosis for flat feet for Foot

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Foot+3 More
Foot orthosis for flat feet - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new imaging system to see if it's effective in detecting changes in posture for people with flat or high arch feet. If successful, the system could help assess the efficiency of plantar orthotics.

Eligible Conditions
  • Foot
  • Feet Pes Planus (Flatfoot)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 3 Secondary · Reporting Duration: Baseline and 12 months

Baseline and 12 months
Change from baseline in body's postural symmetry index at 12 months
Change from baseline in flexion-extension angles of lower body joints during gait at 12 months
Baseline and 2 months
Change from baseline in body's postural symmetry index at 2 months
Change from baseline in flexion-extension angles of lower body joints during gait at 2 months
Baseline and 6 months
Change from baseline in body's postural symmetry index at 6 months
Change from baseline in flexion-extension angles of lower body joints during gait at 6 months

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Normal arches feet (control group)
1 of 3
High arches feet
1 of 3
Flat feet
1 of 3

Active Control

Experimental Treatment

80 Total Participants · 3 Treatment Groups

Primary Treatment: Foot orthosis for flat feet · No Placebo Group · N/A

High arches feet
Device
Experimental Group · 1 Intervention: Foot orthosis for flat feet · Intervention Types: Device
Flat feet
Device
Experimental Group · 1 Intervention: Foot orthoses for high arches feet · Intervention Types: Device
Normal arches feet (control group)NoIntervention Group · 1 Intervention: Normal arches feet (control group) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 12 months

Who is running the clinical trial?

Cryos Technologies Inc.UNKNOWN
Natural Sciences and Engineering Research Council, CanadaOTHER
51 Previous Clinical Trials
2,618 Total Patients Enrolled
TOPMEDLead Sponsor
3 Previous Clinical Trials
55 Total Patients Enrolled
Edith Martin, PhDPrincipal InvestigatorTOPMED
2 Previous Clinical Trials
35 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have no musculoskeletal disorders.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 26th, 2021

Last Reviewed: November 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.